CHAVONA MOORE: Open Payments
NPI 1235724311 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 17 payments from 9 companies in 2025. Trend: 2023 $50 · 2024 $84 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 2 | $87 |
| Lilly USA, LLC | 4 | $65 |
| Exact Sciences Corporation | 2 | $43 |
| ABBVIE INC. | 1 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, REXULTI, MOUNJARO, Cologuard Collection Kit, UBRELVY, CAPLYTA, ACCRUFER, ZEPBOUND.
Industry payments across AL — which companies pay providers there.
